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Specification of retinal rod photoreceptors is deter-
mined by several different transcription factors
that activate expression of rod-specific genes and
repress expression of cone photoreceptor-specific
genes. The mechanism by which this dual regulation
occurs is unclear. We have found that Pias3, a tran-
scriptional coregulator and E3 SUMO ligase that is
selectively expressed in developing photoreceptors,
promotes the differentiation of rod photoreceptors
while preventing rods from adopting cone photore-
ceptor-like characteristics. Pias3 binds the photore-
ceptor-specific transcription factors Crx and Nr2e3
and is specifically targeted to the promoters of
photoreceptor-specific genes. Pias3 SUMOylates
Nr2e3, converting it into a potent repressor of
cone-specific gene expression. Rod- and cone-
specific promoters are bound by hyperSUMOylated
proteins in rod photoreceptors, and blocking
SUMOylation in photoreceptors results in cells
with morphological and molecular features of
cones and an absence of rod-specific markers. Our
data thus identify Pias3-mediated SUMOylation of
photoreceptor-specific transcription factors as a
key mechanism of rod specification.
INTRODUCTION
The vertebrate retina is a well-established system for studying
neuronal specification. Rod photoreceptors are the best-studied
retinal cell type at themolecular level. Several different transcrip-
tion factors act to drive retinal precursors to a rod photoreceptor
fate. Most of these genes are also expressed in mature rods and
regulate both photoreceptor survival and terminal differentiation.
Among these are the paired-type homeodomain genes Crx and
Otx2, which are also expressed in cone photoreceptors, theMaf-
type bZip factor Nrl, and the nuclear hormone receptor Nr2e3
(Chen et al., 1997; Furukawa et al., 1997; Haider et al., 2000;
Mears et al., 2001). Several of these factors not only promote
rod differentiation but also prevent rods from acquiring charac-
teristics of other retinal cells. Among these are Otx2, which
prevents rods from adopting an amacrine fate (Nishida et al.,
2003), and Nrl and Nr2e3, which repress expression of cone-
specific genes in rods (Akhmedov et al., 2000; Chen et al.,
2005; Mears et al., 2001; Peng et al., 2005). Mutation of Nr2e3
in human patients leads to enhanced S-cone syndrome, and
a spontaneous null mutation in Nr2e3 (the rd7/rd7 mouse line)
results in rod photoreceptors that ectopically express S-cone
markers (Haider et al., 2000; Jacobson et al., 2004). It is poorly
understood how these photoreceptor-enriched transcription
factors act as both repressors and activators. In other systems,
however, this dual regulation is achieved by the action of
transcriptional coregulators. Most coregulators are broadly
expressed, and their activity is thought to be regulated by
posttranslational modification and protein-protein interaction
(Lonard and O’Malley, 2006).
Previously, we showed that Pias3 mRNA was selectively
expressed in developing photoreceptors within the retina
(Blackshaw et al., 2004). Protein Inhibitor of Activated Stat3
(Pias3) was first identified as an inhibitor of Stat3-dependent
transcription (Chung et al., 1997). Later studies showed that
Pias3 can act as both a transcriptional coactivator and core-
pressor and regulates the activity of many classes of transcrip-
tion factors in nonneuronal cells, including Smads (Long et al.,
2004), nuclear hormone receptors (Junicho et al., 2000), and
Oct4 (Tolkunova et al., 2007). Pias3 is also an E3 SUMO ligase,
catalyzing covalent linkage of SUMO proteins, which are distant
homologs of ubiquitin, to specific lysine residues on target
proteins. SUMOylation, which in many ways mechanistically
resembles ubiquitination, can reversibly modify the activity of
a broad range of mostly nuclear proteins (Meulmeester and
Melchior, 2008). Pias3 is known to catalyze SUMOylation of
a number of different transcription factors, many of which are
also bound and regulated by Pias3 by SUMOylation-indepen-
dent mechanisms (Kotaja et al., 2002; Schmidt and Muller,
2002). The function of Pias3 in neural development has not
been explored, however. Given the broad range of known
Pias3 targets and its highly cell-specific expression pattern,
we investigated whether Pias3 regulates rod photoreceptor
development by regulating the activity of rod-specific transcrip-
tion factors.234 Neuron 61, 234–246, January 29, 2009 ª2009 Elsevier Inc.
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Pias3 Is Selectively Expressed in Developing Rod
and Cone Photoreceptors
To determine if Pias3 protein was coexpressedwith Pias3mRNA
in developing retina, we performed section immunostaining for
Pias3. We confirmed the specificity of the antibody used by
staining HEK293T cells transfected with a Pias3 overexpression
construct (Figure S1A available online). We first observe weak
expression of Pias3 in the outer region of the outer neuroblastic
layer (ONBL) at postnatal day 0 (P0) (Figure 1A). Immunostaining
with the rod precursor-specific transcription factor Nr2e3
revealed that Pias3 colocalized with Nr2e3. Coincident with
previously reported in situ hybridization data, we observe that
Pias3 protein expression increases in developing rods during
the postnatal interval when rods are terminally specified. Protein
expression peaks at P14 and then declines steadily. By P10, we
also observe a subset of cells in the outer nuclear layer (ONL) that
express Pias3 protein but not Nr2e3 (Figures 1A and 1B, arrow-
heads). We performed double immunohistochemistry for TRb2,
a transcription factor expressed in cone photoreceptors (Jones
et al., 2007), and observed expression of Pias3 in a subset of
TRb2-positive cells (data not shown).
Pias3 Promotes Rod Differentiation and Represses
Expression of Cone-Specific Genes
This selective expression of Pias3 in developing rods suggested
that Pias3 regulates rod specification.We used in vivo electropo-
ration of developing retina to determine the role of Pias3 in
photoreceptor development (Matsuda and Cepko, 2004). After
overexpressing full-length Pias3 under the ubiquitous CAG
promoter (CAG-Pias3, Figures 1D and 1H) at P0, we observed
by P14 a significant (p < 0.05) increase in the number of cells
in the ONL with cell bodies in the inner outer nuclear layer
(IONL) and rod-like morphology that labeled with an anti-
rhodopsin antibody (Rho4D2), compared to cells electroporated
with an empty vector control (CAG-GFP, Figures 1C and 1H).
To quantify the composition of cells electroporated with full-
length Pias3, we performed dissociated cell immunocytochem-
istry with cell-type specific antibody markers for rods (Rho4D2),
cones (cone transducin a subunit, Gnat2), rod bipolars (PKCa),
amacrine cells (syntaxin), and Mu¨ller glia (glutamine synthetase,
GS) (Matsuda and Cepko, 2004; Young et al., 2005). Significantly
more Rho4D2-positive cells (p < 0.005) were observed following
electroporation with full-length Pias3 than with empty vector
(Figure 1I). Fewer syntaxin and GS-positive cells were also seen
(p < 0.05) (Figure 1I). Since rhodopsin is not expressed until
roughly 6 days after rod precursors exit mitosis (Belliveau et al.,
2000), we tested if Pias3 overexpression altered the kinetics of
rhodopsin expression (Figure 1J). No significant increase in the
fraction of rhodopsin-positive cells was observed until P7, and
we conclude that Pias3 does not induce precocious expression
of rhodopsin. We observed that neither the fraction of prolifer-
ating cells (BrdU-positive cells pulsed at P0) nor of apoptotic cells
(TUNEL-positive cells) changed significantly in electroporated
cells following Pias3 overexpression at P7 and P10 (data not
shown). These data suggest that Pias3 overexpression drives
the electroporated retinal precursor cells to a rod cell fate at the
expense of inner retinal cell types.
These data also suggest that Pias3 may directly enhance
rhodopsin expression in transfected rod precursors after the first
postnatal week. We tested the effects of Pias3 on expression of
luciferase driven from a rhodopsin promoter construct in
HEK293T cells. We found that Pias3 activates rhodopsin expres-
sion in a dose-dependent manner in the presence of the photo-
receptor-specific transcription factors Crx, Nrl, and Nr2e3
(Figure S2A). Since Nr2e3 is also known to be a strong transcrip-
tional repressor when bound to its own consensus binding site,
we tested whether Pias3 would have any effect on Nr2e3-medi-
ated transcriptional repression. We found that Pias3 also signif-
icantly enhanced Nr2e3-dependent repression (Figure S2B).
Thus, Pias3 enhances both transcriptional activation and repres-
sion functions of Nr2e3, depending on the reporter tested and on
other factors present.
We next tested the effect of reducing Pias3 expression in
photoreceptor precursors. We used an shRNA expressed using
the U6 promoter (U6-Pias3) that we confirmed to reduce Pias3
expression levels in retinal cells (Figures S1B and S1C). We
observe an increase in the localization of cells electroporated
with the Pias3 shRNA construct (U6-Pias3) in the ONL at P14
when compared to a negative control shRNA (U6-control)
construct (Figures 1E and 1F). Significantly more transfected
cells (p < 0.005) were found in the outer portion of the outer
nuclear layer (OONL) than in controls (Figure 1H), and these cells
had large cell soma and short outer segments, a pattern charac-
teristic of cone photoreceptors. Cells in the ONL electroporated
with control shRNAs rarely expressed the cone-specific markers
Gngt2 (cone transducin g subunit, Figure 1E), Gnat2 (cone trans-
ducin a subunit, Figure 1K), and S-cone opsin (Figure 1M).
However, electroporation with Pias3-specific shRNA resulted
in a dramatic increase (p < 0.005) in the fraction of cells express-
ing cone-specific markers (Figures 1F and 1K). Many photore-
ceptors electroporated with Pias3 shRNA expressed S-opsin,
although the fraction expressing M-opsin was not increased
(Figure 1M). We demonstrated that these shRNA effects are
specific and can be rescued by shRNA-insensitive human
PIAS3 (Figure S1D). We conclude that Pias3 is required to
prevent developing rod photoreceptors from adopting a cone-
like morphology and gene expression pattern.
When several rod-specific transcription factors including Nrl
and Nr2e3 are mutated, cone-specific genes are ectopically
expressed in rod photoreceptors, with S-opsin, but not M-opsin,
being upregulated in these rods (Chen et al., 2005; Haider et al.,
2000; Mears et al., 2001; Peng et al., 2005). In photoreceptors of
micemutant forNr2e3, however, expressionof rod-specificgenes
is only slightly reduced, and hybrid cells showing both rod- and
cone-like gene expression profiles are observed (Chen et al.,
2005; Corbo and Cepko, 2005). We next tested if cells electropo-
rated with Pias3 shRNA expressed both rod-specific and cone-
specific genes. Many rhodopsin-positive cells electroporated
with Pias3 shRNA coexpressed Gnat2, though no cells
expressing control shRNA did (Figure 1L). Quantifying these
results (Figure1K) revealed that over60%ofall rhodopsin-positive
cells electroporated with the Pias3 shRNA expressed cone-
specific markers. Though 35% of all electroporated cellsNeuron 61, 234–246, January 29, 2009 ª2009 Elsevier Inc. 235
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Figure 1. Pias3 Overexpression and Knockdown Influence Photoreceptor Differentiation
(A and B) Developmental expression of Pias3 (red) coimmunostained with Nr2e3 (green) from P0, 4, 7, 10, 14, and 35 (A), and higher-magnification image of the
P10 retina focused on ONL (B). The arrowheads indicate Pias3-positive cells not colabeled with Nr2e3.
(C–F) Section immunohistochemistry of the P14 mouse retinas electroporated in vivo at P0 with CAG-GFP (C), CAG-Pias3 (D), U6-control (E), and U6-Pias3 (F)
labeledwith Rho4D2 (C andD) or Gngt2 (E and F) antibodies. Arrowheads in (E) and (F) indicate GFP-positive cells labeled withGngt2. OONL, outer region of outer
nuclear layer; IONL, inner region of outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer.
(G) Higher-magnification images of (C)–(F) focused on rod or cone outer segments (ROS or COS).
(H) Laminar position of electroporated cell bodies. Fraction of GFP-positive cells found in each retinal lamina is shown. OONL, outer region of outer nuclear layer;
IONL, inner region of outer nuclear layer; INL, inner nuclear layer. Data are represented as mean ± SD. *p < 0.05, **p < 0.005 by Student’s t test (n = 6).
(I) Cell type composition of the P14mouse retinas electroporated in vivo at P0with CAG-GFP andCAG-Pias3 determined by immunostaining with retinal cell type-
specific markers (Rho4D2 for rods, Gnat2 for cones, PKCa for rod bipolars, syntaxin for amacrines, and GS for Mu¨ller glia). *p < 0.05, **p < 0.005 by Student’s
t test (n = 3).
(J) Fraction of Rho4D2-positive cells harvested at P4, P7, and P14. *p < 0.05, **p < 0.005 by Student’s t test (n = 3).
(K) Cell type composition of the P14mouse retinas electroporated in vivo with U6-control and U6-PIAS3. The fraction of Rho4D2+ Gnat2+ indicates Rho4D2 and
Gnat2 double-positive cells shown in (L). *p < 0.05, **p < 0.005 by Student’s t test (n = 3).
(L) Immunohistochemistry of the P14 dissociated retina electroporated in vivo with U6-control and U6-Pias3 labeled with Rho4D2 (blue), GFP (green), and
Gnat2 (red) antibodies. Arrowheads indicate triple-labeled cells.
(M) Immunostaining with S orM opsin antibodies of ONL of retinas electroporated in vivo with U6-control and U6-Pias3. Arrowheads indicate electroporated cells
colabeled with the opsin antibodies.
Scale bar: (A and C–F) 50 mm, (B, G, L, and M) 20 mm.236 Neuron 61, 234–246, January 29, 2009 ª2009 Elsevier Inc.
NeuronexpressedGnat2, in comparison toonly 4% in the control, roughly
30% of all electroporated cells expressed both Gnat2 and
rhodopsin. The number of cells expressing only Gnat2 was not
different between the two samples. Thus, we conclude that these
cells, despite showingacone-likemorphology, are actually rods in
which repression of cone-specific genes has been compro-
mised—a phenotype like that seen with loss of Nr2e3 function.
We also measured expression of other cell-specific markers
usingdissociatedcell immunohistochemistry in the samemanner
as for the overexpression studies shown in Figure 1I.We observe
a slight reduction in the number of rhodopsin-positive cells
following Pias3 knockdown (Figure 1K), along with a general
reduction in the level of rhodopsin expression in each transfected
cell (data not shown), consistent with a possible role for Pias3 in
activation of rhodopsin expression (Figure S2A). We observe no
changes in the fraction of PKCa or syntaxin-positive cells, but
a significant decrease (p < 0.05) in the fraction of GS-positive
Mu¨ller glia (Figure 1K), along with a reduction in the fraction of
cells in the INL relative to controls (p < 0.05) (Figure 1H).
Pias3 Interacts with Nr2e3 and Crx In Vitro and In Vivo
Since Pias3 is known to interact with multiple different classes of
transcription factors in nonneuronal cells, we tested whether
Pias3 interactedwith known photoreceptor-specific transcription
factors. We performed coimmunoprecipitation using 35S-labeled
in vitro translated proteins to determine whether Pias3 directly
interacted with Crx and Nr2e3. Antibodies against both native
Crx and Nr2e3 immunoprecipitate radiolabeled Pias3 (Figure 2A,
lanes1–4). Antibodies toNr2e3were shown to immunoprecipitate
B
A Figure 2. Pias3 Interacts with Nr2e3 and Crx
In Vitro and in Mouse Retina
(A) In vitro coimmunoprecipitation of Pias3 with
Nr2e3 and Crx. Co-IP was performed using
in vitro translated proteins with (*) or without
35S-labeling and the indicated IP antibodies (lanes
1–6 and 9–12). Lanes 7, 8, 14, and 15 are input
controls without IP.
(B) Co-IP of Pias3, Nr2e3, and Crx from postnatal
day 10 retina of the indicated mouse strains.
Proteins are detected via immunoblot with indi-
cated antibodies. Nuclear extracts made from
pooled retinal samples were immunoprecipitated
(IP) using an antibody against one of the three
proteins. Lanes 1–2, 6–7, and 11–12 are input
controls without IP.
radiolabeled Crx in a Nr2e3-dependent
manner (Figure 2A, lanes 5 and6) as previ-
ously reported (Peng et al., 2005).
We next tested if Pias3 interacted with
Nr2e3 and Crx in vivo. We performed
co-IP using nuclear extracts of P10 retina
from wild-type, Crx/, and rd7/rd7
(Nr2e3 null) strains. Immunoprecipita-
tions were performed using antibodies
against one of each of these three
proteins and probed with all three anti-
bodies. Immunoprecipitation using an
anti-Crx antibody co-IPs Nr2e3, as previously reported (Chen
et al., 2005; Cheng et al., 2004), as well as Pias3 from wild-
type mice (Figure 2B, lane 3). Co-IP does not occur with
a nonspecific IgG (Figure 2B, lane 5) or in Crx/ mice where
Crx protein is absent (Figure 2B, lane 4). Similarly, anti-Nr2e3
antibodies can immunoprecipitate Pias3 and Crx from wild-
type retina (Figure 2B, lane 8) but not from rd7/rd7 mice
(Figure 2B, lane 9). Co-IP did not occur when control IgG was
used for wild-type retinal extracts (Figure 2B, lane 10). Finally,
antibodies to native Pias3 can immunoprecipitate Crx and
Nr2e3 from wild-type retina (Figure 2B, lane 13). However, no
Nr2e3 protein can be immunoprecipitated with anti-Pias3 from
rd7/rd7 retinas, while Crx protein can still be co-IPed
(Figure 2B, lane 14). IgG controls do not precipitate any of these
proteins (Figure 2B, lane 15), demonstrating the specificity of the
anti-Pias3 antibody. Together, these data imply that Pias3 inter-
acts directly with both Nr2e3 and Crx in vivo and in vitro and that
this interaction is independent of either Nr2e3 or Crx. Given that
these three proteins are coexpressed in developing photorecep-
tors and that Nr2e3 and Crx form a complex in vivo (Cheng et al.,
2004; Peng et al., 2005), we conclude that Nr2e3 and Crx are
physiological targets of Pias3.
We next tested whether the effects of Pias3 overexpression
and knockdownwere altered in rd7/rd7 animals. Overexpression
of Pias3 in this background does not result in the increase in the
cells in the inner outer nuclear layer (IONL), where the over-
whelming majority of cells are rod photoreceptors (Figure S3).
Significantly fewer cells with cone-like morphology and cell
bodies in the outer outer nuclear layer (OONL) (p < 0.005) areNeuron 61, 234–246, January 29, 2009 ª2009 Elsevier Inc. 237
Neuronseen in rd7/rd7 retinas electroporated with Pias3 shRNA
compared to wild-type retinas electroporated with the same
construct, though more are seen than in retinas electroporated
with control shRNA. Finally, all rd7/rd7 retinas showed more
electroporated GS-positive INL cells with Mu¨ller glia-like
morphology than in wild-type. Neither CAG-Pias3 nor U6-Pias3
constructs repressedMu¨ller glial development in rd7/rd7 retinas,
implying a role for Nr2e3 in repression of glial development.
Pias3 Is Selectively Present on the Promoters of Rod
and Cone-Specific Genes that Are Known Targets
of Crx and Nr2e3
Although the preceding data suggest that Pias3 interacts with
Nr2e3 and Crx in vivo, we sought to confirm whether or not
Pias3 is found together with Nr2e3 and Crx on the promoter
regions of photoreceptor-specific genes.Wefirst performed chro-
matin immunoprecipitation (ChIP) using antibodies to either Pias3
or Nr2e3 individually. We found that, as previously reported (Peng
et al., 2005) antibodies to Nr2e3 selectively immunoprecipitate
chromatin from promoters of rod and cone-specific genes such
as rhodopsin, M- and S-cone opsin, and rod-specific phosphodi-
esterase b subunit, while promoters of genes selectively
expressed in nonphotoreceptor cell types, such as bipolar cells
and retinal ganglion cells, or of genes not expressed in the retina,
such as albumin, are not immunoprecipitated with this antibody
(Figure 3, lanes 1–3). We find that antibodies to Pias3 show the
same pattern of immunoprecipitation as Nr2e3 (Figure 3, lanes
4–6). To determine whether Pias3 and Nr2e3 co-occupy the
same promoters, we performed double ChIP (Figure 3, lanes 7–
12), and the same pattern of immunoprecipitation was observed.
Similar results were obtained using quantitative single and double
ChIP for rhodopsin, M- and S-opsin, and mGluR6 (Figure S4A).
Promoter occupancy of each single ChIP experiment is 40%,
the values of which are in line with other previously reported
ChIP studies (Masui et al., 2007; Miotto and Struhl, 2008). From
this we conclude that Pias3 and Nr2e3 co-occupy the same sets
of promoters in rod photoreceptor cells. However, this does not
imply that Pias3 binding to these promoters requires both Nr2e3
and Crx. We performed ChIP assays for these same sequences
fromCrx/ and rd7/rd7mice and found that Pias3 is still immuno-
precipitated from each photoreceptor promoter tested in either
mutant background (Figure S4B), suggesting that neither protein
is necessary to target Pias3 to these promoters.
Pias3 Catalyzes SUMOylation of Nr2e3, and
SUMOylation-Deficient Mutants of Pias3 No Longer
Effectively Promote Rod Differentiation
Since Pias3 can regulate target transcription factors both by
direct protein-protein interaction and by its E3 SUMO ligase
activity, we tested whether the E3 ligase activity is required for
regulation of rod development by Pias3. Mutant forms of Pias3
tested included a double point mutation in the RING domain
(C299S, H301A) that blocks the E3 SUMO ligase activity of
Pias3 (Long et al., 2004). Pias3 also contains an LXXLL coregu-
lator recruitment motif in its N-terminal domain (Jang et al.,
2004), which can be inactivated by mutation of the terminal
two leucines to alanines (Liu et al., 2001).
Tocharacterize the interactionofPias3andNr2e3, 35S-labeled-
deletion mutants of Pias3 were tested for interaction with full-
length Nr2e3 (Figure S5). We found both the N-terminal domain
and the RING domains of Pias3 are sufficient for interaction with
Nr2e3 in vitro. Since SUMO1was predicted to be themost abun-
dant retinal SUMO isoform based on our previous SAGE study
(Blackshawet al., 2004), we next determined if Pias3 can catalyze
additionofSUMO1 toNr2e3andwhetherPias3-Nr2e3 interaction
wasaffectedby the functional pointmutations, first confirming the
specificity of the SUMO1 antibody for immunoblot and immuno-
precipitation (Figure S6A). HEK293T cells were cotransfected
with plasmids containing wild-type mouse Nr2e3, and wild-type
and mutant forms of both Pias3 and Flag-tagged SUMO1. We
observe bands at 72 and 85 kD with both anti-Nr2e3 and
anti-Flag, indicating that Flag-tagged SUMO1 is conjugated
to Nr2e3 in the presence of wild-type Pias3 (Figure 4A, lanes 1
and 9), corresponding to both di- and tri-SUMOylated forms of
Nr2e3. The SUMOylation-deficient (DSUMO) RING domain
mutant of Pias3, as expected, does not catalyze conjugation of
Flag-SUMO1 to Nr2e3 to generate tri-SUMOylated Nr2e3
(Figure 4A, lane 5), although some di-SUMOylated Nr2e3 is
Figure 3. Pias3 and Nr2e3 Selectively Co-occupy the
Promoters of Photoreceptor-Specific Genes
Single and double chromatin immunoprecipitation (ChIP)
assays were performed using P14 mouse retinas. Results
are shown as gel images of PCR products representing
promoter sequences of the indicated candidate genes: IP,
single or double immunoprecipitation with the indicated anti-
bodies; –, nonspecific IgG controls (for double ChIP, the indi-
cated specific antibody was used in the first IP, and a control
IgG was used in the second IP); Inp, input without IP as a posi-
tive control for PCR. The candidate genes are shown based on
the retinal cell type in which they are selectively expressed,
with non Pias3/Nr2e3 target genes, which are not expressed
in photoreceptor genes, shown in the three bottom lanes
(BP, bipolar; GC, ganglion cells).238 Neuron 61, 234–246, January 29, 2009 ª2009 Elsevier Inc.
Neuronobserved with the anti-Flag antibody in both the DSUMO sample
and the sample lacking transfected Pias3. We interpret this data
to suggest that other E3 SUMO ligases in the HEK293T cells
used may SUMOylate Nr2e3. Unexpectedly, mutation of the
LXXLL domain (LXXAA) also blocks the ability of Pias3 to catalyze
SUMOylation of Nr2e3 (Figure 4A, lane 3), with no di- or tri-
SUMOylated Nr2e3 seen in the presence of this mutant using
that anti-Flag antibody (Figure 4A, lane 11). We speculate that
this mutant may, through mechanisms that are unclear, have
a dominant-negative effect on the activity of endogenous E3
SUMO ligases that generate the di-SUMOylated form of Nr2e3.
Interaction of Nr2e3 and Pias3, however, was unaffected in any
of the mutants tested (Figure 4A, lanes 17–22).
We next tested whether these mutant forms of Pias3 show
altered ability to regulate rod photoreceptor development
in vivo. We found that the morphology of cells electroporated
with the DSUMO or LXXAA mutant forms of Pias3 were much
like those electroporated with empty vector, but more GS-
positive Mu¨ller glia were seen (Figure 4B, white arrowheads).
We also observed more cells expressing Gngt2 in the ONL (Fig-
ure 4B, upper panel, orange arrowheads), along with Gnat2 and
S-cone opsin (data not shown). We find that, unlike wild-type
Pias3, overexpression of both mutant forms of Pias3 does not
result in additional cells in the ONL (Figure 4C). We next per-
formed dissociated cell immunostaining to quantify changes in
cell composition resulting from overexpression of mutant forms
of Pias3. Neither mutant produced an increase in rhodopsin-
positive cells, unlike wild-type Pias3 (Figure 4D). Moreover,
a SUMOylase-deficient mutant of the human ortholog of Pias3,
unlike wild-type human PIAS3, did not rescue the reduction in
rhodopsin seen following Pias3 knockdown (Figure S1D). More
electroporated cells expressed the cone marker Gnat2 for
both mutants relative than in either wild-type Pias3 or in vector
control (p < 0.05). We observed that a number of electroporated
A
B C
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Figure 4. Nr2e3 Is SUMOylated by Pias3,
and the RING (E3 SUMO Ligase) Domain of
Pias3 Is Necessary for Its Function in Photo-
receptor Development
(A) Pias3 catalyzes SUMOylation of Nr2e3 in an
E3-ligase-dependent manner. Whole-cell extracts
were prepared from HEK293T cells cotransfected
with pCAG-Nr2e3, pCAG-Pias3 (wild-type, LXXAA
or DSUMO mutant), and pTag-FLAG-SUMO1, or
the respective empty vector controls ‘‘–’’). The
presence of SUMO1-modified forms of Nr2e3
and the interaction of Pias3 with Nr2e3 were
analyzed by immunoprecipitation (IP) using anti-
Nr2e3 antibody p183 and immunoblotting (IB)
using antibodies to Nr2e3 (p183, lanes 1–8),
FLAG-SUMO1 (anti-FLAG M2 monoclonal, Sigma;
lanes 9–16), and Pias3 (Sigma, lanes 17–24).
Red brackets indicate potential di- and tri- (T/D)
SUMOylated Nr2e3 catalyzed by the recombinant
PIAS3. Green asterisks mark di-SUMOylated
Nr2e3, which may represent SUMOylation cata-
lyzed by other endogenous E3 SUMO ligases.
The green arrow in the FLAG IB blot points out
background staining derived from Nr2e3 IB. The
black open circle indicates the expected size for
the Pias3. Input controls without IP were shown
in lanes 25–48, demonstrating the expression of
recombinant Nr2e3, FLAG-SUMO1, and Pias3
proteins by transfected 293 cells.
(B) Immunostaining of P14 retinas with GS (upper)
or Gngt2 (lower) antibodies electroporated in vivo
at P0 with CAG-GFP and Pias3 LXXAA and
DSUMO mutants. White and orange arrowheads
indicate electroporated cells labeled with the anti-
bodies used.
(C) Fraction of GFP-positive cells found in the
OONL, IONL, and INL. Pias3 LXXAA and DSUMO
mutants have significantly fewer cells in the IONL
than Pias3 wild-type. All data are represented as
mean ± SD. *p < 0.05, **p < 0.005 by Student’s
t test (n = 6).
(D) Cell type composition of the P14 mouse retinas
electroporated in vivo with CAG-GFP, CAG-Pias3, LXXAA, and DSUMO determined by immunostaining with retinal cell type-specific markers. *p < 0.05,
**p < 0.005 by Student’s t test (n = 3).
(E) Immunohistochemistry of the P14 dissociated retina electroporated in vivo with CAG-GFP, LXXAA, and DSUMO with Rho4D2 (blue), GFP (green), and Gnat2
(red) antibodies. Arrowheads indicate triple-labeled cells. Scale bar: (B) 50 mm, (E) 20 mm.Neuron 61, 234–246, January 29, 2009 ª2009 Elsevier Inc. 239
Neuroncells coexpressed both rhodopsin and Gnat2 (Figure 4E). This
phenotype is reminiscent of that seen with Pias3 knockdown
(Figure 1L), although the increase in Gnat2-expressing cells is
less dramatic. DSUMO mutants of Pias3 also failed to enhance
Nr2e3-mediated transcriptional repression in HEK293T cells
(Figure S2B). This suggests that these mutant forms of Pias3
act in vivo as partial dominant-negative mutations. Both mutant
forms of Pias3 also lead to an increase in the number of Mu¨ller
glia (Figure 4B). The mechanism of this effect is unclear.
Nr2e3 Is SUMOylated on Multiple Sites In Vitro and
In Vivo, and SUMOylation of Nr2e3 Is Necessary for Its
Ability to Repress Cone-Specific Genes In Vivo
Following up on the finding that Pias3 can SUMOylate Nr2e3
in vitro and in vivo, we sought to characterize the residues in
Nr2e3 that can be SUMOylated. Analysis of mouse Nr2e3
sequence using SUMOplot (http://www.abgent.com/doc/
sumoplot) identified three high-probability sites for SUMOyla-
tion, at K178, K315 and K322 (Figure 5A), which are highly evolu-
tionarily conserved. We tested whether these residues were
necessary for SUMOylation of Nr2e3, constructing K to R point
mutations for each of these sites individually and also a construct
in which all three lysines had beenmutated. We first tested these
using transfected HEK293T cells and found that wild-type forms
of Nr2e3 show two SUMOylated products, corresponding in size
to potentially di- and tri-SUMOylated isoforms, in the presence
of Pias3 (Figure 5B, lane 1). Triple-mutant forms of Nr2e3 are
not SUMOylated (Figure 5B, lane 9). Finally, mutation of the
K178 residue drastically affected the pattern and levels of
SUMOylation of Nr2e3 (Figure 5B, lane 3). In this mutant isoform,
the di-SUMOylated form of Nr2e3 was not observed in the pres-
ence of Pias3, although reduced levels of tri-SUMOylated Nr2e3
were still observed, presumably reflecting usage of a cryptic
nonconsensus SUMOylation site. No change in SUMOylation
levels or pattern was observed in either the K315R or K322R
mutants (Figure 5B, lanes 5 and 7). Together, these results
suggest that the observed di-SUMOylated form of Nr2e3 results
from SUMOylation at K178 and at either K315 or K322.
We next investigated whether Nr2e3 is indeed SUMOylated in
developing retina. We performed immunoprecipitation assays
from both wild-type and rd7/rd7 retina using antibodies directed
against both Nr2e3 and SUMO1. Immunoprecipitation with anti-
Nr2e3 followed by immunoblotting with anti-SUMO1 detects
a band at70 kD that corresponds to the size of di-SUMOylated
Nr2e3 observed in transfected HEK293T cells (Figure 5C, lane 1).
This band is not detectable in retinas of rd7/rd7mice with either
anti-SUMO1 (Figure 5C, lane 2) or with anti-Nr2e3 (Figure 5C,
lane 7). The anti-SUMO1 antibody recognizes a protein that
runs at roughly the same size as SUMOylated Nr2e3 in the input
lane (Figure 5C, lane 5, asterisk). However, since this band is not
immunoprecipitated with anti-Nr2e3 and is also present in
retinas from rd7/rd7 animals, we conclude that it does not repre-
sent SUMOylated Nr2e3 but rather another SUMOylated protein
that coincidentally has a similar electrophoretic mobility.
To determinewhether SUMOylation of Nr2e3 is essential for its
function in vivo, we tested if overexpression of SUMOylation-
deficient mutants of Nr2e3 could rescue defects observed in
rd7/rd7 animals. We electroporated wild-type Nr2e3 and
SUMOylation-deficient mutants of Nr2e3, along with empty
vector controls, into P0 rd7/rd7 animals and examined the
phenotypes at P14. In retinas electroporated with empty vector,
we observemany electroporated photoreceptors that are double
labeled with S-opsin, consistent with previously published data
(Figure 5D) (Chen et al., 2005; Peng et al., 2005).We also observe
more electroporated cells with Mu¨ller glial morphology that
express GS than in wild-type animals. This may represent gliosis
associated with the retinal rosettes seen in rd7/rd7 animals or
elsemay represent an unreported function of Nr2e3 in repressing
Mu¨ller glial differentiation. Electroporation of wild-type Nr2e3
results in a reduced number of cells expressing S-cone opsin
(Figure 5D, white arrowheads), consistent with previous studies
demonstrating a role of Nr2e3 in directly repressing S-cone opsin
expression (Peng et al., 2005) along with a substantial reduction
in the number ofMu¨ller glia (Figure 5D, red arrowheads) and other
cells of the INL (Figure 5E), indicating that wild-type Nr2e3
partially rescues the phenotype observed in rd7/rd7 animals.
Electroporation of single SUMOylation-deficient mutants reveals
that the K178R mutant does not efficiently rescue the rd7/rd7
phenotype, as indicated by the large number of S-cone opsin
positive photoreceptors and the increase in the number of cells
with cone-like morphology in the outer ONL (p < 0.005) (Figures
5Dand5E). In fact, the number of cellswith cone-likemorphology
(though not the number of cells expressing S-opsin) is greater in
the K178R mutant than in vector control alone, suggesting that
overexpression of K178R may disrupt the function of endoge-
nous photoreceptor-specific transcription factors such as Crx
and Nrl that are known to interact with Nr2e3 (Chen et al., 2005;
Cheng et al., 2004). However, K315R and K322R mutants
rescued both the morphology and S-opsin expression pheno-
types at a level roughly equal to wild-type Nr2e3 (Figures 5D
and 5E). These in vivo data are consistent with the pattern of SU-
MOylation observed in transfected cells (Figure 5B). Finally, we
observed that the triple-mutant form of Nr2e3 not only did not
rescue the rd7/rd7 phenotype in electroporated photoreceptors
but appeared to enhance the mutant phenotype, generating
a significantly higher fraction of cells located in the outer ONL
compared to vector control and many more photoreceptors
expressing S-cone opsin (p < 0.005) (Figures 5D and 5E). Similar
resultswereobserved inwild-type retinas electroporatedwith the
triple-mutant form of Nr2e3, suggesting that mutant Nr2e3 may
interfere with the activity of wild-type Nr2e3 or associated
proteins such as Nrl (Cheng et al., 2004). Triple-mutant forms of
Nr2e3 also failed to show any increase in transcriptional repres-
sion of HEK293T cells in the presence of Pias3, while SUMO1-
Nr2e3 fusion proteins repressed transcription more efficiently
than wild-type Nr2e3 (Figure S2B). Moreover, SUMO1-Nr2e3
fusions rescued the phenotype seen in rd7/rd7 cells as efficiently
as wild-type Nr2e3 (Figures 5D and 5E). These data indicate that
Pias3-dependentSUMOylation is needed formaximal repression
of cone-specific transcription by Nr2e3.
The Promoters of Rod- and Cone-Specific Genes Are
HyperSUMOylated, and SUMOylation Is Essential for
Normal Photoreceptor Differentiation
To see if SUMOylation is associated with the promoters of
photoreceptor-specific genes that are bound by Nr2e3, we240 Neuron 61, 234–246, January 29, 2009 ª2009 Elsevier Inc.
Neuronperformed single and double ChIP for Nr2e3 and SUMO1. Both
single and double ChIP revealed similar results. We observed
that the promoters of both rod- and cone-specific genes are
hyperSUMOylated relative to the promoters of genes selectively
expressed in nonphotoreceptor cell types, or not expressed in
the retina (Figures 6A andS6B). Sincewe observe hyperSUMOy-
lation of rod and cone-specific promoters following initial immu-
noprecipitation with Nr2e3, this implies that rod- and cone-
specific promoters are hyperSUMOylated in rod photoreceptors,
implying that SUMOylation is associated with both transcription-
ally active and inactive photoreceptor-specific promoters in
these cells.
We next tested the effects of global inhibition of SUMOylation
on photoreceptor development. The adenoviral protein Gam1
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Figure 5. SUMOylation of Nr2e3 Is Required for Repression of Cone-Specific Genes in Rod Photoreceptors
(A) Schematic structure of Nr2e3 is shown together with three predicted SUMOylation sites.
(B) Nr2e3 is SUMOylated by Pias3 at three potential sites. SUMOylation assays were performed using wild-type and mutant forms of Nr2e3 protein expressed in
HEK293T cells.Whole-cell extracts were prepared fromHEK293T cells cotransfected with thewild-type and fourmutant forms of pCAG-Nr2e3, pCAG-Pias3, and
pTag-FLAG-SUMO1 with ‘‘–’’ as empty vector controls. Red brackets indicate the predicted di- or tri-SUMOylated forms of Nr2e3. Anti-Pias3 IB indicates that
interaction of Nr2e3 and Pias3 is preserved in all combinations of Pias3 and Nr2e3 mutants. Anti-Nr2e3 IB is used to normalize loading.
(C) Nr2e3 is di-SUMOylated in themouse retina. Immunoprecipitates fromP10wild-type or rd7/rd7 retina were analyzed for the presence of SUMOylated forms of
Nr2e3 using immunoblotting with anti-SUMO1 (upper) and anti-Nr2e3 (lower). A red asterisk marks an unknown SUMOylated protein running at a same position
as Nr2e3-SUMO in the input lane of the rd7/rd7 retinas.
(D) P14 rd7/rd7 or CD1 retinas electroporated in vivo with Nr2e3, SUMO1-fused Nr2e3 (SUMO1-Nr2e3), and the loss of SUMOylation mutants (K178R, K315R,
K322R, and triple mutant) immunostained with S-opsin antibody. White arrowheads indicate electroporated photoreceptors colabeled with S-opsin, and red
arrowheads indicate electroporated cells with Mu¨ller glial morphology. Scale bar, 50 mm.
(E) Fraction of the GFP-positive cells localized at OONL, ONL, and INL (upper graph) and S-opsin positive cells (lower graph) in rd7/rd7mice electroporated with
the indicated construct as shown in (D). Data are represented as mean ± SD. *p < 0.05, **p < 0.005 by Student’s t test (n = 6).Neuron 61, 234–246, January 29, 2009 ª2009 Elsevier Inc. 241
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Figure 6. Photoreceptor-Specific Promotes Are HyperSUMOylated and SUMOylation Regulates Rod Photoreceptor Development
(A) Nr2e3 target promoters are hyperSUMOylated. Single and double ChIP assays were performed on P14 mouse retina using rabbit anti-Nr2e3 and/or mouse
anti-SUMO1 antibodies. Results are shown as gel images of PCR products representing promoter sequences of the indicated candidate genes: IP, single or
double immunoprecipitation with the indicated antibodies; –, nonspecific IgG controls (For double ChIP, the indicated specific antibody was used in the first
IP, and a control IgG was used in the second IP); Inp, input without IP as positive controls for PCR. The candidate genes are shown based on the expressing
cell types in the retina with non-Nr2e3 target genes in the three bottom lanes (BP, bipolar; GC, ganglion cells).
(B–G) Section immunohistochemistry of the P14mouse retinas electroporated in vivo with CAG-GFP (B and D) and Gam1 (C and E–G) immunostainedwith Gngt2
(B and C), Rho4D2 (D and E), S-opsin (F), and M-opsin (G) antibodies. Scale bar, 50 mm.
(H) Fraction of the GFP-positive cells localized at ONL labeled with Rho4D2, S-opsin, or M-opsin. Data are represented as mean ± SD. *p < 0.05, **p < 0.005 by
Student’s t test (n = 3).has been identified as a dominant-negative inhibitor of SUMOE1
ligase (Boggio et al., 2004). Since all forms of SUMOylation
use the same E1 ligase, overexpression of Gam1 abolishes
all cellular SUMOylation. Overexpression of Gam1 in developing
retina from P0 results in photoreceptors adopting a cone-like
morphology and ectopically expressing Gngt2 (Figure 6C). We
also observed more S-cone opsin positive cells compared
to vector control (p < 0.05) (Figures 6F and 6H). This suggests
that loss of SUMOylation results in a failure to repress cone-
specific gene expression in rods, as is seen with knockdown
of Pias3 and overexpression of SUMOylation-deficient mutants
of Nr2e3. However, these cells also lack detectable rhodopsin
expression (Figure 6E). We thus conclude that loss of SUMOy-
lation not only results in ectopic expression of S-cone-specific
genes in rods but is required for normal expression of
rhodopsin.
DISCUSSION
Pias3 Promotes Rod Development, Repressing
Expression of Cone-Specific Genes in Rods
Pias3 protein is first weakly detectable in developing photore-
ceptors at birth, with expression peaking in the postnatal
week. This spatial and temporal expression pattern corresponds
almost precisely with that of the known photoreceptor-specific
transcription factors Crx, Nrl, and Nr2e3 and closely matches
the previously published Pias3mRNA expression pattern (Black-
shaw et al., 2004). Since Pias3 can regulate many different
classes of transcription factors, we hypothesized that it might
act in vivo to regulate the function of multiple photoreceptor-
specific transcription factors. We tested this hypothesis using
overexpression and knockdown of Pias3 and observed that
Pias3 overexpression led to an increased number of242 Neuron 61, 234–246, January 29, 2009 ª2009 Elsevier Inc.
Neuronrhodopsin-positive, rod-like cells in the ONL and fewer inner
retinal cells relative to controls, while Pias3 knockdown gener-
ates photoreceptors with cone-like morphology and molecular
features but which still express rod-specific genes. Curiously,
both overexpression and knockdown of Pias3 also lead to
a reduced number ofMu¨ller glial cells, an effect that is dependent
on the presence of Nr2e3. This may imply that an intermediate
level of Pias3 expression in photoreceptor precursor cells may
permit some to adopt a glial fate, while high or low levels of
Pias3 may commit these cells to a photoreceptor fate. Alterna-
tively, Pias3 overexpression might mimic loss of function by
titrating proteins that direct glial specification away from their
endogenous targets.
Pias3 Interacts with Photoreceptor-Specific
Transcription Factors and Regulates Expression
of Photoreceptor-Specific Genes
The increase in rod photoreceptor number seen following Pias3
overexpression is like that seen following Crx overexpression
(Furukawa et al., 1997). Likewise, the ectopic expression of
S-cone-specific transcripts seen in rods where Pias3 expression
has been knocked down resembles that seen in mice mutant for
Nr2e3. We found that Pias3 interacts with both these proteins
in vivo and is selectively targeted to the promoters of photore-
ceptor-specific genes. It is likely that Crx and Nr2e3, however,
do not represent the full set of Pias3 targets in rod photorecep-
tors. Crx and Nr2e3 can be found as part of a multiprotein
complex along with Nrl,, Crx, and the nuclear hormone receptor
Nr1d1 in vivo (Chen et al., 2005; Cheng et al., 2004), We have
observed that Pias3 can be immunoprecipitated from postnatal
retina as part of a complex containing both Nrl and Otx2, and
Pias3 can directly bind both these proteins in vitro (data not
shown). It is thus possible that Pias3 may in part function as
a bridging protein to facilitate the assembly of this transcription
factor complex on photoreceptor promoters.
Pias3-Mediated SUMOylation of Nr2e3 Is Required
for Repression of Cone-Specific Genes in Rods
Nr2e3, which is bound to the promoters of both rod- and cone-
specific genes in developing rod photoreceptors, is a transcrip-
tional activator on the promoters of rod-specific genes but
represses the expression of cone photoreceptor-specific genes
in vivo. Since other identified photoreceptor-specific transcrip-
tion factors such as Crx and Nrl are also present at each of these
promoters (Peng et al., 2005), the mechanism of this divergent
transcriptional regulation has been a mystery. We provide
evidence that suggests that this may be mediated by selective
SUMOylation of Nr2e3 by Pias3. We demonstrate that not only
does Pias3 directly SUMOylate Nr2e3 and that Nr2e3 is SUMOy-
lated in developing retina but that SUMOylation-deficient
mutants of Nr2e3 fail to rescue the mutant phenotype in rd7/
rd7 mice. Pias3 enhances Nr2e3-mediated transcriptional
repression in heterologous cells, and this effect is dependent
on the presence of both the SUMO ligase of Pias3 and the
SUMOylated lysine resides in Nr2e3. SUMOylation of Nr2e3
appears to be critical for repression of cone-specific genes,
but it does not seem to be the only target of Pias3 in this
pathway. Though Pias3 knockdown results in a less dramatic
increase in cells with cone-like morphology and gene expression
pattern in rd7/rd7 animals than in wild-type, we still observe an
increase in cone-like cells over controls (Figure S3B). This
suggests that other transcription factors that repress cone-
specific gene expression, among them Nrl, may also be physio-
logical targets of Pias3.While loss of function of Pias3 leads to an
upregulation of S-opsin but M-opsin expression in rods, essen-
tially phenocopying the rd7/rd7 in this respect (Chen et al., 2005;
Corbo and Cepko, 2005; Peng et al., 2005), Pias3 protein is
found associated with the promoters of both S- and M-opsin
genes in rod photoreceptors, along with Nr2e3 (Figure 3). The
reason why M-opsin is not upregulated following loss of function
of either Pias3 or Nr2e3 is still unclear, although the presence of
an additional cone-specific factor, such as the thyroid hormone
receptor TRb2 (Ng et al., 2001), may be necessary to allow
expression of M-opsin.
SUMOylation of the Promoters of Photoreceptor-
Specific Genes Coordinates Normal Photoreceptor
Development
Many nuclear proteins are SUMOylated in vivo. SUMOylation
has been traditionally thought of a signal for transcriptional
repression and chromatin silencing (Gill, 2005; Girdwood et al.,
2004). It has been proposed that SUMOylation may serve as
a general signal for recruitment of histone deacetylases that
trigger transcriptional silencing, or else may target SUMOylated
DNA-protein complexes to regions of the nucleus associated
with transcriptional silencing. Recent data, however, have
suggested that SUMOylation of transcription factors may also
lead to transcriptional activation (Lyst and Stancheva, 2007),
though the mechanism by which this occurs is unclear. Our
data suggests that hyperSUMOylation is a general property of
both rod and cone-specific promoters in rod photoreceptor
cells, but is not detectable in rods on promoters of genes that
are selectively expressed in nonphotoreceptor cells of the retina.
We hypothesize that this reflects the modification of substrate
proteins, among them Nr2e3, by Pias3 targeted to these
promoters.
Though we have shown that SUMOylated Nr2e3 represses
cone-specific gene expression in rods, it is not clear if this repre-
sents the only SUMOylated protein found on the promoters of
cone-specific genes (Figure 6A). Other than Nr2e3 itself, the
identity of these SUMOylated proteins is unclear. Phosducin is
the only SUMOylated mammalian photoreceptor-specific
protein identified to date (Klenk et al., 2006). Phosducin is local-
ized mainly in photoreceptor outer segments, and SUMOylation
alters its stability and interaction with the b and g subunits of
transducin. It has been suggested that phosducin may also
interact with Crx to regulate transcription of photoreceptor-
specific genes (Zhu and Craft, 2000). If nuclear phosducin is
indeed associated with photoreceptor promoters, it would
represent a possible substrate for Pias3-dependent modifica-
tion. One additional potential retinal target is phosphorylated
Stat3, which was the first identified biochemical target of Pias3
(Chung et al., 1997), and can both inhibit rod photoreceptor
development and promote Mu¨ller glial differentiation. However,
the expression patterns of Pias3 protein and pStat3 overlap little
in developing retina, with pStat3 expression undetectable inNeuron 61, 234–246, January 29, 2009 ª2009 Elsevier Inc. 243
Neuronphotoreceptor precursors by the time Pias3 expression is seen
(Goureau et al., 2004; Ozawa et al., 2004; Zhang et al., 2004),
and it is questionable whether pStat3 is a major retinal target
of Pias3.
The function of SUMOylation in neural development is
obscure. One recent study has demonstrated that Sox10 activity
during neural crest development is modified by SUMOylation
(Taylor and Labonne, 2005), while another has shown that
SUMOylation ofMef2C by Pias1 canmodulate dendrite develop-
ment in cerebellar granule neurons (Shalizi et al., 2006, 2007).
Here, our data directly link SUMOylation to specification of
a specific subtype of neuron.
Pias3 as Central Coordinator of Rod Photoreceptor
Development
Attention has historically focused on DNA-binding transcription
factors as the key determinants of regional patterning and cell-
fate specification. Pias3 is one of a handful of transcriptional cor-
egulators with highly cell- or tissue-specific expression patterns
that have been identified. A few of these coregulators have been
shown to play a critical role in developmental processes,
including Dach1 in organogenesis (Li et al., 2003), and myocar-
din in smooth and cardiac muscle development (Wang et al.,
2001, 2003). Pias3 represents the first protein in this category
to play a clear role in neuronal cell-fate specification.
Based on these data, we conclude that Pias3 plays a multi-
functional role in the regulation of photoreceptor development.
Our findings suggest that Pias3 acts to promote rod photore-
ceptor development by modulating the activity of photoreceptor
proteins, among them Nr2e3 and Crx (Figure 7). Though expres-
sion of rod-specific genes is dependent on Pias3-mediated
SUMOylation, it is not yet clear which proteins must be SUMOy-
lated for this effect. Whatever the relevant SUMOylated factors
are for regulating expression of rod-specific genes, it is unlikely
that these include Nr2e3, as both the DSUMO mutant of Pias3
and the triple SUMOylation-deficient mutant of Nr2e3 activate
transcription of rhodopsin in heterologous cells equally as well
as the wild-type forms of both proteins (Figure S2A). We interpret
our results to show that Pias3 binds Nr2e3when it is bound to the
promoters of cone-specific genes and also SUMOylates it, con-
verting it to a strong transcriptional repressor and ensuring that
only rod-specific genes are expressed in rod photoreceptors.
Pias3 thus acts to both enhance rod-promoting and confer
cone-repressing functions on its target proteins, though the rele-
vant targets of Pias3-dependent SUMOylation in activation of
rod-specific genes remain to be determined (Figure 7). It is likely
that the targets of Pias3 are not limited to Crx and Nr2e3, and
further studies will clarify its mechanism of action.
EXPERIMENTAL PROCEDURES
Animals
Timed pregnant CD1mice were purchased fromCharles River Breeding Labo-
ratories. C57BL/6J and rd7/rd7mice were purchased from the Jackson Labo-
ratory. A Crx/mouse was provided by C. Cepko at Harvard Medical School.
All experimental procedures were preapproved by JHMI animal care and the
Institutional Animal Care and Use Committee of Washington University School
of Medicine, and conformed to the guidelines of the Association for Research
in Vision and Ophthalmology for the use of live animals in vision research.
DNA Constructs
Details for all cDNA constructs used in this study are shown in Table S1.
In Vivo Electroporation
In vivo electroporation were performed at P0 as previously described (Mat-
suda and Cepko, 2004). Approximately 0.3 ml of DNA solutions (5 mg/ml) was
injected into the subretinal space of P0 mouse pups, and square electric
pulses (100 V; five 50 ms pulses with 950 ms intervals) were applied with
tweezer-type electrodes (BTX, model 522). pCAGIG vector was coelectropo-
rated (1 mg/ml) with both shRNA constructs to allow for visualization of trans-
fected cells. The electroporated retinas were harvested at P4, P7, and P14
for immunohistochemistry.
Immunohistochemistry
For section immunohistochemistry, retinas were fixed with 4% paraformalde-
hyde in PB for 1 hr at room temperature, cryoprotected in PBS containing
15% sucrose overnight at 4C, embedded in OCT compound (Sakura), and
cryosectioned (20 mm). For dissociated cell immunohistochemistry, retinas
were separated into single cells as described (Matsuda and Cepko, 2004)
and plated on poly-D-lysine-coated glass slides and fixed for 5 min at room
temperature. Images were taken on a fluorescence light microscope (Axio-
skop2, Carl Zeiss) or a scanning confocal microscope (Meta 510, Carl Zeiss).
Sources and dilutions of all antibodies used are listed in Table S2. A minimum
of three retinas from two different litters were examined for each construct
tested for section immunohistochemical analysis. For dissociated cell count-
ing, a minimum of 100 cells that were positive for both GFP and the marker
in question were counted from a minimum of three separate electroporation
experiments.
Coimmunoprecipitation, Western Blotting,
and In Vitro SUMOylation Assays
In vitro co-IP assays were performed using in vitro transcribed/translated
recombinant proteins with or without 35S-labeling. Recombinant PIAS3,
CRX, and NR2E3 proteins weremade from the corresponding pcDNA3.1/HisC
Figure 7. Model for Action of Pias3 in Photo-
receptor Differentiation
‘‘S’’ indicates SUMOylated proteins, while ‘‘X’’
indicates an unidentified SUMOylated factor
present on the promoters of rod-specific genes.
Pias3 in rods binds and SUMOylates Nr2e3 to
repress expression of S-cone-specific genes and
simultaneously activates expression of rod-
specific genes via a SUMOylation-dependent
mechanism. Since Pias3-dependent activation of
rod-specific genes does not require SUMOylation
of Nr2e3 (see Figure S2), Pias3 must SUMOylate
other transcription factors on rod-specific
promoters (shown here as X).244 Neuron 61, 234–246, January 29, 2009 ª2009 Elsevier Inc.
Neuronmammalian expression vectors using TnT T7 Quick Coupled Transcription/
Translation Kit (Promega). Co-IPs were performed as described previously
(La Spada et al., 2001) with minor modifications in the wash buffer (50 mM
Tris-Cl [pH 7.4], 150400 mM NaCl, and 0.5% Triton X-100) and antibodies
described in Table S2. In vivo co-IP assays were performed using retinal
nuclear extracts made from P10 wild-type or mutant mice as described previ-
ously (Peng and Chen, 2007), with antibodies used detailed in Table S2. The
results were detected and visualized using the Millipore Western Blotting
Detection System (Millipore, Billerica, MA) and Amersham Hyperfilm (GE
Healthcare). Cell based co-IP and SUMOylation assays were performed as
described in Supplemental Experimental Procedures section.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation has performed as described (Peng et al.,
2005). The results of ChIP assays were analyzed using candidate gene-based
PCR with primers spanning the promoter region of each gene (listed in Peng
et al. [2005]). Results shown are representative of at least three separate
experiments. Controls include the use of normal rabbit/mouse IgG (Santa
Cruz) in immunoprecipitation reactions (negative controls) and input (without
IP) as positive controls in PCR reactions. Double chromatin immunoprecipita-
tion assays (double ChIP) were performed using a modification of a previously
described protocol (Geisberg and Struhl, 2004). Details are described in the
Supplemental Experimental Procedures.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, six
figures, and two tables and can be found with this article online at http://
www.neuron.org/supplemental/S0896-6273(08)01054-4.
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